Loading clinical trials...
Loading clinical trials...
Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)
Conditions
Interventions
Methotrexate
Locations
31
United States
University of Southern California
Los Angeles, California, United States
University of Colorado
Denver, Colorado, United States
Shafran Gastroenterology
Winter Park, Florida, United States
Atlanta Gastroenterology
Atlanta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
The University of Chicago
Chicago, Illinois, United States
Start Date
February 1, 2012
Primary Completion Date
April 1, 2017
Completion Date
April 1, 2017
Last Updated
April 17, 2018
NCT06372613
NCT07550673
NCT07374471
NCT06071312
NCT05739864
NCT04338204
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions